Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Zimdahl

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Cancer Cell|February 21, 2012
aSIRTing control over cancer stem cellsTakahiro Ito, Bryan Zimdahl, Tannishtha Reya
Cancer Research|February 15, 2015
Fearful symmetry: subversion of asymmetric division in cancer development and progressionJeevisha Bajaj, Bryan Zimdahl, Tannishtha Reya
Journal of Cancer Research and Clinical Oncology|July 1, 2022
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphomaPengcheng He, Haibo Liu, Bryan Zimdahl, et al.
Nature Communications|July 19, 2016
High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivoClaire S Koechlein, Jeffrey R Harris, Timothy K Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2016
Control of inflammation by stromal Hedgehog pathway activation restrains colitisJohn J Lee, Michael E Rothenberg, E Scott Seeley, et al.
Cell Discovery|November 28, 2018
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine releaseYiyang Xu, Zhiyuan Yang, Lucas H Horan, et al.
Nature Genetics|February 4, 2014
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemiaBryan Zimdahl, Takahiro Ito, Allen Blevins, et al.
Nature Communications|November 27, 2020
A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemiaKyle Spinler, Jeevisha Bajaj, Takahiro Ito, et al.
Nature|July 20, 2010
Regulation of myeloid leukaemia by the cell-fate determinant MusashiTakahiro Ito, Hyog Young Kwon, Bryan Zimdahl, et al.
Nature|June 10, 2016
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinomaRaymond G Fox, Nikki K Lytle, Dawn V Jaquish, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Cell|February 21, 2012
aSIRTing control over cancer stem cellsTakahiro Ito, Bryan Zimdahl, Tannishtha Reya
Cancer Research|February 15, 2015
Fearful symmetry: subversion of asymmetric division in cancer development and progressionJeevisha Bajaj, Bryan Zimdahl, Tannishtha Reya
Journal of Cancer Research and Clinical Oncology|July 1, 2022
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphomaPengcheng He, Haibo Liu, Bryan Zimdahl, et al.
Nature Communications|July 19, 2016
High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivoClaire S Koechlein, Jeffrey R Harris, Timothy K Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2016
Control of inflammation by stromal Hedgehog pathway activation restrains colitisJohn J Lee, Michael E Rothenberg, E Scott Seeley, et al.
Cell Discovery|November 28, 2018
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine releaseYiyang Xu, Zhiyuan Yang, Lucas H Horan, et al.
Nature Genetics|February 4, 2014
Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemiaBryan Zimdahl, Takahiro Ito, Allen Blevins, et al.
Nature Communications|November 27, 2020
A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemiaKyle Spinler, Jeevisha Bajaj, Takahiro Ito, et al.
Nature|July 20, 2010
Regulation of myeloid leukaemia by the cell-fate determinant MusashiTakahiro Ito, Hyog Young Kwon, Bryan Zimdahl, et al.
Nature|June 10, 2016
Image-based detection and targeting of therapy resistance in pancreatic adenocarcinomaRaymond G Fox, Nikki K Lytle, Dawn V Jaquish, et al.
Pageof 2